About Dr Reetu Jain
Dr. Reetu Jain is the Director of the Bone Marrow Transplant (BMT) Programme and Academics at Jaslok Hospital and Research Centre, Mumbai, with 25+ years of experience in medical oncology, haemato-oncology, and stem cell transplantation.
- 25+ years of experience in medical oncology and bone marrow transplantation; 300+ successful BMTs at Jaslok Hospital
- Residency in Medical Oncology, Tata Memorial Hospital, Mumbai (1999–2002)
- 330+ successful stem cell harvests at Jaslok Hospital
- Recognised by Indian Express as Top Medical Oncologist, Mumbai 2022; TOI Healthcare Leader's Award in Medical Oncology 2023
- Core Executive Committee Member — Indian Society of Bone Marrow Transplant (ISBMT); International collaborative research with National Cancer Institute, USA
OPD Schedule Of Dr Reetu Jain
Consultation Fees Rs. N/A /-
Global Hospitals, Mumbai
Qualifications & Credentials
Medical Degrees
- MBBS — Mumbai University
- MD (Internal Medicine) — INS Aswini Hospital, Mumbai University, 1998
Fellowships & Special Training
- Residency in Medical Oncology — Tata Memorial Hospital, Mumbai (July 1999–November 2002)
- Additional Training in Haematological Malignancies & Solid Tumours — Tata Memorial Hospital, Mumbai
- International Collaborative Research — National Cancer Institute (NCI), USA
Certifications & Accreditations
- Core Executive Committee Member — Indian Society of Bone Marrow Transplant (ISBMT)
- Maharashtra Medical Council Registration
Areas of Expertise
Major Conditions Treated
- Leukaemia (AML, ALL, CML, CLL)
- Lymphoma (Hodgkin & Non-Hodgkin)
- Multiple Myeloma
- Aplastic Anaemia
- Thalassemia (BMT-eligible)
- Sickle Cell Anaemia
- Fanconi Anaemia
- Neuroblastoma & Germ Cell Tumours
- Sarcomas
- Breast Cancer (Chemotherapy & Medical Management)
Sub-specialties
- Bone Marrow Transplantation (BMT): Director of BMT Programme at Jaslok Hospital; 300+ successful transplants including autologous and allogeneic procedures — a leading BMT specialist in Mumbai, India.
- Haemato-Oncology: Expert in all types of blood cancers and lymphoid malignancies, including CML management with TKIs.
- Stem Cell Mobilisation & Harvest: 330+ successful stem cell harvests using internationally benchmarked protocols.
Advanced Procedures & Treatments
- Autologous Stem Cell Transplantation
- Allogeneic BMT (Sibling & Unrelated Donor)
- Stem Cell Mobilisation & Harvest (Peripheral Blood)
- Dasatinib & TKI Therapy for CML
- CHOP, R-CHOP, ABVD Regimens for Lymphoma
- High-Dose Chemotherapy Conditioning Regimens
- Intrathecal Chemotherapy
- Immunotherapy (Checkpoint Inhibitors)
List of Disease and Treatment for which Dr Reetu Jain can be consulted
Professional Experience
Current Affiliation
- Jaslok Hospital and Research Centre, Mumbai — Director, BMT Programme & Academics, February 2021–Present
Past Affiliations
- Jaslok Hospital and Research Centre, Mumbai — Honorary Medical Oncologist & Stem Cell Transplant Physician (February 2004–January 2021)
- Tata Memorial Hospital, Mumbai — Residency, Medical Oncology (July 1999–November 2002)
Academic & Research Roles
- Core Executive Committee Member — Indian Society of Bone Marrow Transplant (ISBMT)
- Invited Speaker — National and International Oncology Conferences (Ongoing)
- International Collaborative Research — National Cancer Institute (NCI), USA
- Book Chapter Author: 'Out-Patient Management of BMT Patient After Discharge' (API Textbook of Medicine)
- Book Chapter Author: 'Dasatinib in CML' (Haematology Education Book)
- Book Chapter Author: 'Special Aspects of Management of Lymphomas in Developing Countries' (International Textbook of Lymphoid Neoplasm)
Key Achievements
- 300+ successful BMTs at Jaslok Hospital — survival rates comparable to leading international centres
- 330+ successful stem cell harvests
- Top Medical Oncologist, Mumbai — Indian Express Group, 2022
- TOI Healthcare Leader's Award in Medical Oncology — Times of India, December 2023
- Lupin Oncology Award for Contribution in the Field — March 2023
- Best Clinical Presentation Award and Best Premium Poster Award (Oncology Conferences)
Awards & Recognitions
National & International Awards
- Top Medical Oncologist, Mumbai — Indian Express Group, 2022
- TOI Healthcare Leader's Award in Medical Oncology — Times of India Group, December 2023
- Lupin Oncology Award for Contribution in the Field — March 2023
- Best Clinical Presentation Award — Oncology Conference
- Best Premium Poster Award — Oncology Conference
Professional Memberships
- Indian Society of Bone Marrow Transplant (ISBMT) — Core Executive Committee
- Indian Society of Medical & Paediatric Oncology (ISMPO)
- Maharashtra Medical Council
Research & Publications
Published Papers (Selected)
- Jain R, et al. 'Comparison of LACE with BCNU-Containing Conditioning Regimen in Lymphoma Transplant.' (Journal details not publicly listed; contact hospital for citation.)
- Book Chapter: 'Out-Patient Management of BMT Patient After Discharge.' API Textbook of Medicine.
- Book Chapter: 'Dasatinib in Chronic Myeloid Leukaemia.' Haematology Education Book.
- Book Chapter: 'The Way to Treat CLL is Chemo Immunotherapy.' Haematology Today.
- Book Chapter: 'Special Aspects of Management of Lymphomas in Developing Countries.' International Textbook of Lymphoid Neoplasm.
- Jain R. Postgraduate Dissertation: 'Spectrum of Upper Gastrointestinal Bleeding.' Mumbai University (as part of MD degree).
Ongoing Research & Clinical Interests
- BMT outcomes in haemoglobinopathies (thalassemia, sickle cell)
- Novel conditioning regimens in allogeneic transplant
- CAR-T and immunotherapy in haematological malignancies
Estimated Treatment Costs
| Procedure / Consultation | Estimated Cost (INR) | Estimated Cost (USD) |
|---|---|---|
| Medical Oncology Consultation | ₹1,200 – ₹3,000 | $14 – $36 |
| Chemotherapy (per cycle, regimen-dependent) | ₹25,000 – ₹1,80,000 | $300 – $2,160 |
| Autologous BMT | ₹6,00,000 – ₹12,00,000 | $7,200 – $14,400 |
| Allogeneic BMT (Sibling Matched) | ₹12,00,000 – ₹22,00,000 | $14,400 – $26,400 |
| Stem Cell Mobilisation & Harvest | ₹80,000 – ₹2,00,000 | $960 – $2,400 |
*Indicative estimates only. Actual costs subject to hospital pricing, case complexity, and insurance. Contact Cancer Rounds for a personalised quote.
Frequently Asked Questions
1. What advanced technologies does Dr. Reetu Jain use in medical oncology and BMT treatment?
Dr. Jain leads one of Mumbai's most active BMT programmes, employing internationally benchmarked conditioning regimens, peripheral blood stem cell mobilisation protocols, and the latest TKI therapies (dasatinib, imatinib) for CML. She has collaborated with the National Cancer Institute, USA, ensuring access to global oncology standards.
2. What conditions does Dr. Reetu Jain specialise in treating?
Dr. Jain specialises in leukaemia (AML, ALL, CML, CLL), lymphoma, multiple myeloma, aplastic anaemia, thalassemia requiring BMT, and solid tumours requiring chemotherapy. Patients from across India and internationally seek her for bone marrow transplant and haemato-oncology care in Mumbai.
3. How do I book an appointment with Dr. Reetu Jain?
Appointments with Dr. Reetu Jain can be booked directly through the Cancer Rounds website or by contacting their international patient department for priority scheduling.
4. Can international patients receive treatment from Dr. Reetu Jain?
Yes. Cancer Rounds provides full assistance for international patients seeking treatment from Dr. Reetu Jain, including medical visa invitation letters, airport transfers, and local accommodation coordination.
5. What support is available for international patients?
International patients benefit from a dedicated concierge service provided by Cancer Rounds, including language interpretation, financial counselling, and pre-travel virtual consultations to review medical records before arrival.
6. Does Dr. Reetu Jain offer second opinions for medical oncology and BMT cases?
Yes. Second opinion consultations for blood cancers, BMT eligibility, and complex haematological conditions can be arranged via Cancer Rounds, connecting patients with Mumbai's foremost BMT specialist and medical oncologist.














